Edwards Lifesciences has further to run

EW recently had a nice earnings beat and guidance raise. It is showing strong momentum and has broken out of a multi-year pattern. I bought a couple weeks ago, it may be vulnerable to some consolidation shortly but I think it will finish the year strongly. My target is $160 with a stop at $114.